ClinicalTrials.gg

Meningitis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 268 studies for Meningitis across more than 10 countries. 28 are recruiting or about to start. 91 of them are mainly about Meningitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 4 narrower conditions too, such as Meningitis, Meningococcal: 431 studies, 58 open.

Status

Completed
196
Status unknown
24
Recruiting
17
Terminated
10
Not yet recruiting
9
Withdrawn
5

Phase

Phase 3
63
Phase 2
53
Phase 4
27
Phase 1
19
Early Phase 1
2

Where

United States
84
United Kingdom
24
France
19
Canada
15
China
12
Puerto Rico
9

Who develops what

Add Meningitis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 1 program from 1 company, 1 with this as their studies’ main aim; 0 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
Meningococcal VaccinesEarlier only
Evidence
  • NCT03652610 · GlaxoSmithKline · Phase 2 · comparator · “Licensed GSK MenACWY vaccine (Menveo)” · registered Aug 2018
  • NCT03587207 · GlaxoSmithKline · Phase 2 · comparator · “MenACWY (Menveo) vaccine” · registered Jun 2018
  • NCT03205358 · Sanofi · Phase 2 · comparator · “Meningococcal Polysaccharide groups A, C, W-135 and Y Conjugate Vaccine” · registered Jun 2017
  • NCT03077438 · Sanofi · Phase 3 · comparator · “Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine” · registered Mar 2017
  • NCT02842853 · Sanofi · Phase 3 · comparator · “Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine” · registered Jul 2016
—00 studies
13-valent pneumococcal vaccineEarlier onlyPhase 4 trial recorded
Evidence
  • NCT03621670 · GlaxoSmithKline · Phase 3 · background · “Prevnar13” · registered Jul 2018
  • NCT01049035 · Sanofi · Phase 2 · background · “Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)” · registered Jan 2010
Pfizer73% of its industry studies00 studies
HiberixEarlier only
Evidence
  • NCT00771849 · Sanofi · Phase 2 · comparator · “Haemophilus Influenzae Type b (Hib) vaccine” · registered Oct 2008
  • NCT00474526 · Novartis · Phase 3 · background · “Hib” · registered May 2007
GlaxoSmithKline86% of its industry studies00 studies

3 more in limited or earlier use — sign in to see them, free.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 1 program — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Meningitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 17 Meningitis studies recruiting now, 11 (65%) set no upper age limit and 6 (35%) stop at 75 or younger. 7 (41%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (12%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
106 (35%)6 (35%)
1814 (82%)14 (82%)
3013 (76%)13 (76%)
4013 (76%)13 (76%)
5013 (76%)13 (76%)
6512 (71%)12 (71%)
7512 (71%)12 (71%)
8511 (65%)11 (65%)

Across all 268 studies, recruiting or not: 59% stop at 75 or younger and 57% at 65; 69% take children; 3% are for women only and 1% for men only; 50% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Meningitis studies take

Of 19 phase 3 interventional studies under Meningitis, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 210 mo5–18 · 13 studies——
Phase 315 mo7–28 · 19 studies——
Interventional, no phase28 mo10–34 · 24 studies——
Observational33 mo15–96 · 29 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 268. Browse all 268 → or search them.